Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1239740.RAfbr6CxyWHR0JQUK-VYr2AVqc4tq8yUyouTcyQpUc1eo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1239740.RAfbr6CxyWHR0JQUK-VYr2AVqc4tq8yUyouTcyQpUc1eo130_assertion type Assertion NP1239740.RAfbr6CxyWHR0JQUK-VYr2AVqc4tq8yUyouTcyQpUc1eo130_head.
- NP1239740.RAfbr6CxyWHR0JQUK-VYr2AVqc4tq8yUyouTcyQpUc1eo130_assertion description "[During the median follow-up time of 57 months, 350 children developed at least one persistent IA (GAD antibody, IA-2A, or micro insulin autoantibodies) and 84 of them progressed to T1D.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239740.RAfbr6CxyWHR0JQUK-VYr2AVqc4tq8yUyouTcyQpUc1eo130_provenance.
- NP1239740.RAfbr6CxyWHR0JQUK-VYr2AVqc4tq8yUyouTcyQpUc1eo130_assertion evidence source_evidence_literature NP1239740.RAfbr6CxyWHR0JQUK-VYr2AVqc4tq8yUyouTcyQpUc1eo130_provenance.
- NP1239740.RAfbr6CxyWHR0JQUK-VYr2AVqc4tq8yUyouTcyQpUc1eo130_assertion SIO_000772 25422107 NP1239740.RAfbr6CxyWHR0JQUK-VYr2AVqc4tq8yUyouTcyQpUc1eo130_provenance.
- NP1239740.RAfbr6CxyWHR0JQUK-VYr2AVqc4tq8yUyouTcyQpUc1eo130_assertion wasDerivedFrom befree-2016 NP1239740.RAfbr6CxyWHR0JQUK-VYr2AVqc4tq8yUyouTcyQpUc1eo130_provenance.
- NP1239740.RAfbr6CxyWHR0JQUK-VYr2AVqc4tq8yUyouTcyQpUc1eo130_assertion wasGeneratedBy ECO_0000203 NP1239740.RAfbr6CxyWHR0JQUK-VYr2AVqc4tq8yUyouTcyQpUc1eo130_provenance.